Evidence map›Paper›PMID 35739972›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Dipeptide of ψ-GSH Inhibits Oxidative Stress and Neuroinflammation in an Alzheimer's Disease Mouse Model.

Abbas Raza, Wei Xie, Kwan-Hyun Kim, Venkateshwara Rao Dronamraju, Jessica Williams, Robert Vince, Swati S More

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Abbas RazaCenter for Drug design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Wei XieCenter for Drug design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Kwan-Hyun KimCenter for Drug design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0003-4975-2839
Venkateshwara Rao DronamrajuCenter for Drug design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Jessica WilliamsCenter for Drug design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Robert VinceCenter for Drug design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Swati S MoreCenter for Drug design, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0002-8733-2029
University of Minnesota · US

Funding

Role of glyoxalase-1 in Alzheimer's disease pathogenesis and therapyR01AG062469 · NIA · UNIVERSITY OF MINNESOTA · PI MORE, SWATI S · 2019 to 2023
$1.9M
Center for Drug Design, University of Minnesota NANIA NIH HHS R01 AG062469NIH HHS R01AG062469
6 · The paper itself

Abstract

Supplementation of glutathione (GSH) levels through varying formulations or precursors has thus far appeared to be a tenable strategy to ameliorate disease-associated oxidative stress. Metabolic liability of GSH and its precursors, i.e., hydrolysis by the ubiquitous γ-glutamyl transpeptidase (γ-GT), has limited successful clinical translation due to poor bioavailability. We addressed this problem through the design of γ-GT-resistant GSH analogue, ψ-GSH, which successfully substituted in GSH-dependent enzymatic systems and also offered promise as a therapeutic for Alzheimer's disease (AD). With the aim to improve its bioavailability, we studied the utility of a ψ-GSH precursor, dipeptide

Indexed as

Alzheimer’s diseaseantioxidantglutathioneneuroinflammationoxidative stressprecursorψ-GSH

Identifiers

PMID35739972
PMCPMC9219802
OpenAlexW4282035269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.